InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-26.9%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Blackwell Kimberly, Director. Director active across 1 company, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 13 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €48k. History available since 4 June 2021. The latest transaction was disclosed on 1 February 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
250,000 shares0Common StockSEC:0001725160-24-000026:0
5,000 shares@ US$10.289612.6% of flowCommon StockSEC:0001725160-23-000200:0
Ideal exit: 9 Aug 2024 (T+270)
244,800 shares0Common StockSEC:0001725160-23-000018:0
1,000 shares@ US$47.8011.0% of flowCommon StockSEC:0001725160-22-000005
1,000 shares@ US$47.800.015% mcap12.6% of flowCommon StockSEC:0001725160-22-000005:0
1,000 shares@ US$47.800.015% mcap12.7% of flowCommon StockSEC:0001725160-21-000231:0
1,000 shares@ US$47.8011.1% of flowCommon StockSEC:0001725160-21-000231
1,000 shares@ US$47.8010.8% of flowCommon StockSEC:0001725160-21-000210
1,000 shares@ US$47.800.014% mcap12.4% of flowCommon StockSEC:0001725160-21-000210:0
1,000 shares@ US$47.8010.8% of flowCommon StockSEC:0001725160-21-000207
1,000 shares@ US$47.800.014% mcap12.3% of flowCommon StockSEC:0001725160-21-000207:0
5,000 shares0Common StockSEC:0001725160-21-000143:0
5,000 shares0Common StockSEC:0001725160-21-000143
13 of 13 declarations
About Blackwell Kimberly
Kimberly Blackwell is a Board Member at Zentalis Pharmaceuticals, Inc. As a board member, she participates in the governance and strategy of the company. Her experience is an asset for the organization's development.
